Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Alabama at Birmingham
With
American Heart Association
Age
19–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participants 19 years or older with mild to moderate CKD (eGFR 15 - 59 ml/min/1.73 m2) by the CKD-EPI formula, with vitamin D deficiency (25(OH)D \< 30 ng/ml), and with absolute iron deficiency (TSAT \< 20 and Ferritin \<100) or iron restriction (TSAT \< 20 and Ferritin \> 100).
You may not be if
Active vitamin D analog therapy or history of recent (\< 3 months) use.
Nutritional vitamin D (cholecalciferol or ergocalciferol) therapy in dosages greater than 2000 IU/day.
Subjects receiving erythropoiesis stimulating agents or intravenous iron therapy.
Oral iron therapy started within the last 3 months.
Hb \< 8.0 g/dL for males and Hb \<7.0 g/dL for females.
Pregnancy or lactation.
Serum calcium \> 10.0 mg/dL or phosphorus \> 4.5 mg/dL.
Subjects with acute kidney injury or rapidly declining GFR.
Subjects on hemodialysis, peritoneal dialysis, or having a functioning renal transplant.
Focus of active inflammation such as acute gout, rheumatoid arthritis or active infection determined clinically.
